CoWIN App: The Drugs Controller General of India (DCGI) on 3rd January 2021, gave the green light for the emergency use of two coronavirus vaccines, Covishield and Covaxin. The first one developed by pharmaceutical giant AstraZeneca and Oxford University is being produced in the country by the Serum Institute, while the second vaccine – which is India’s first indigenous vaccine against COVID-19 – is developed by Hyderabad-based company Bharat Biotech.
And tomorrow on January 16th, prime minister Narendra Modi will start the world’s biggest vaccination drive. Notably, the vaccines will be administered to three crore people, 1 crore healthcare workers, and 2 crore frontline workers, for free in the first phase. For this vaccination process, the central government has introduced an application named CoWIN (Covid Vaccine Intelligence Work).
CoWIN App availability
This app is currently not available in any app store either Apple or Google play store. So, avoid downloading the fake apps from the app store which are trying to steal your data.
CoWIN App: Registration Process
There is a form on the portal for registration asking for information such as name, address, age, medical condition. After filling in all the data, you’ll need to select a photo identity card that will be used for verification. When you visit the vaccination center, the same ID will be matched before giving the dose.
When you submit the form, an SMS will be sent to your registered mobile number. Then you have to wait for the vaccination schedule to come to your phone via SMS.
Which ID proof is valid?
According to a document released by the Ministry of Health on Friday, one of these IDs can be given at the time of registration:
Health Insurance Smart Card
MP/MLAs/LEGISLATIVE COUNCIL Members Identity Card
Bank/Post Office Passbook Passport Pension Document Service
Card of Government Employees
Price of COVID-19 Vaccine in India
Price has not been official yet for the common people but the proposed MRP has been set up to Rs 1,000 per dose of the vaccine.
Notably, the government has purchased Covishield, manufactured by Serum Institute for Rs 200 per dose. While Bharat Biotech’s Covaxin has been purchased by the government for the price of Rs 295.